We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Clorox (CLX) Q4: Wall Street Projections for Key Metrics
Read MoreHide Full Article
In its upcoming report, Clorox (CLX - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.54 per share, reflecting a decline of 7.8% compared to the same period last year. Revenues are forecasted to be $1.97 billion, representing a year-over-year decrease of 2.4%.
The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Clorox metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Net Revenue- Health and Wellness' will reach $637.42 million. The estimate indicates a change of -2.1% from the prior-year quarter.
The consensus among analysts is that 'Net Revenue- International' will reach $293.87 million. The estimate suggests a change of -3.7% year over year.
Analysts forecast 'Net Revenue- Lifestyle' to reach $319.12 million. The estimate points to a change of -4.2% from the year-ago quarter.
Analysts expect 'Net Revenue- Household' to come in at $653.18 million. The estimate points to a change of -1.5% from the year-ago quarter.
Analysts' assessment points toward 'Organic Sales Growth' reaching -0.7%. The estimate compares to the year-ago value of 14%.
Based on the collective assessment of analysts, 'Organic Revenue Growth - International' should arrive at 7.7%. The estimate is in contrast to the year-ago figure of 14%.
It is projected by analysts that the 'Organic Revenue Growth - Lifestyle' will reach -3.7%. The estimate is in contrast to the year-ago figure of 14%.
The collective assessment of analysts points to an estimated 'Organic Revenue Growth - Household' of -2.3%. Compared to the present estimate, the company reported 14% in the same quarter last year.
The combined assessment of analysts suggests that 'Organic Revenue Growth - Health and Wellness' will likely reach -1.4%. The estimate compares to the year-ago value of 14%.
The consensus estimate for 'Income before income taxes- Health and Wellness' stands at $161.66 million. Compared to the current estimate, the company reported $176 million in the same quarter of the previous year.
The average prediction of analysts places 'Income before income taxes- International' at $25.42 million. Compared to the current estimate, the company reported $15 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Income before income taxes- Lifestyle' should come in at $65.13 million. The estimate is in contrast to the year-ago figure of $67 million.
Over the past month, Clorox shares have recorded returns of -1.4% versus the Zacks S&P 500 composite's -0.4% change. Based on its Zacks Rank #3 (Hold), CLX will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into Clorox (CLX) Q4: Wall Street Projections for Key Metrics
In its upcoming report, Clorox (CLX - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.54 per share, reflecting a decline of 7.8% compared to the same period last year. Revenues are forecasted to be $1.97 billion, representing a year-over-year decrease of 2.4%.
The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Clorox metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Net Revenue- Health and Wellness' will reach $637.42 million. The estimate indicates a change of -2.1% from the prior-year quarter.
The consensus among analysts is that 'Net Revenue- International' will reach $293.87 million. The estimate suggests a change of -3.7% year over year.
Analysts forecast 'Net Revenue- Lifestyle' to reach $319.12 million. The estimate points to a change of -4.2% from the year-ago quarter.
Analysts expect 'Net Revenue- Household' to come in at $653.18 million. The estimate points to a change of -1.5% from the year-ago quarter.
Analysts' assessment points toward 'Organic Sales Growth' reaching -0.7%. The estimate compares to the year-ago value of 14%.
Based on the collective assessment of analysts, 'Organic Revenue Growth - International' should arrive at 7.7%. The estimate is in contrast to the year-ago figure of 14%.
It is projected by analysts that the 'Organic Revenue Growth - Lifestyle' will reach -3.7%. The estimate is in contrast to the year-ago figure of 14%.
The collective assessment of analysts points to an estimated 'Organic Revenue Growth - Household' of -2.3%. Compared to the present estimate, the company reported 14% in the same quarter last year.
The combined assessment of analysts suggests that 'Organic Revenue Growth - Health and Wellness' will likely reach -1.4%. The estimate compares to the year-ago value of 14%.
The consensus estimate for 'Income before income taxes- Health and Wellness' stands at $161.66 million. Compared to the current estimate, the company reported $176 million in the same quarter of the previous year.
The average prediction of analysts places 'Income before income taxes- International' at $25.42 million. Compared to the current estimate, the company reported $15 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Income before income taxes- Lifestyle' should come in at $65.13 million. The estimate is in contrast to the year-ago figure of $67 million.
View all Key Company Metrics for Clorox here>>>
Over the past month, Clorox shares have recorded returns of -1.4% versus the Zacks S&P 500 composite's -0.4% change. Based on its Zacks Rank #3 (Hold), CLX will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>